New Research by Dr. Raymond Douglas on Protecting Hearing with Teprotumumab Dosing in Thyroid Eye Disease Patients#USA#New_Orleans#Thyroid_Eye_Disease#Teprotumumab#Raymond_Douglas
New Research by Dr. Raymond Douglas on Protecting Hearing with Teprotumumab Dosing in Thyroid Eye Disease Patients
Dr. Raymond Douglas reveals groundbreaking research on spacing teprotumumab doses to safeguard hearing in patients with thyroid eye disease, potentially transforming treatment protocols.
third-news.com
October 12, 2026 at 2:49 PM
New Research by Dr. Raymond Douglas on Protecting Hearing with Teprotumumab Dosing in Thyroid Eye Disease Patients#USA#New_Orleans#Thyroid_Eye_Disease#Teprotumumab#Raymond_Douglas